Commercialising an Innovative Nutraceutical Manufacturing Process

Manufacturing

THE CLIENT

Asian Conglomerate

Region

Asia

Industry

Nutraceuticals

Division

Specialty Chemicals

THE CHALLENGE

Our Client, a diversified major manufacturer, had developed a novel process for the manufacturing of oligosaccharides. They knew their product represented a significant improvement over the state-of-the-art equipment on the market, but before they felt comfortable pursuing its commercialisation, they wanted to understand the risks posed by competing solutions that might still be under development.

 

They also needed guidance on taking their device from a small-scale prototype to a commercially-viable product, with advice on solving the technical and the marketing challenges involved in this process.

4

experts assembled for

the consulting team.

40

competing technologies identified and evaluated.

8

weeks were spent for project delivery.

THE SOLUTION

CamIn recruited four scientific and industry experts into our team. After confirming the Client’s initial evaluation of the current competitive market, CamIn searched for similar technologies under development in university laboratories and at research institutes. For each of the technologies that we identified, our team evaluated its strengths and weaknesses compared to the Client’s new solution.

 

After evaluating the Client’s product and understanding the unique value proposition of their novel process, we developed a plan for the commercialisation of their technology.

THE IMPACT

Our team’s evaluation of the Client’s product identified ways that it could be improved prior to commercialisation, and identified specific applications for their process that would take advantage of its strengths. We also identified particular regions where the commercialisation of their product would be most effective, and advised the Client on actionable steps they should take over the short- and long-term to achieve their goals. Thanks to their innovative technology and our advice, the Client successfully commercialised their device and has become a key player in the specific market segment that CamIn had advised them to pursue.

WOULD YOU LIKE TO LEARN MORE?

If you are looking to invest into emerging technologies, grow your innovation portfolio, and expand into new lucrative areas then we are ready to share our insights with you.

Dr Marcos Gallego Llorente

Principal

Manufacturing

m.gallego [at] camin.com

+34 697 403 767

Dr Dirk Mersch

Managing Director

North American Region

d.mersch [at] camin.com

+1 (512) 988-2454

MANUFACTURING

EU INFRASTRUCTURE MNC

Technology and industrial landscape of emerging technology portfolios and innovation eco-systems for East Asian construction companies. 

 

READ MORE

MANUFACTURING

EU Oil & Gas SME

Technology landscaping, forecasting and identification of  opportunities for non-bio and bio-polyurethane technologies and identifying opportunities.

READ MORE

MANUFACTURING

EU MANUFACTURING MNC

State of the art, landscape and forecast for manufacturing of high-security optical micro- and nanofeatures and nanoimprinting.

 

READ MORE

See how our other Manufacturing clients benefited from engaging with CamIn.

visit

European Region

St John's Innovation Centre

Cowley Road

CB4 0WS Cambridge

United Kingdom

+44 (0)1223 926 926

North American Region

3532 Bee Caves Road

Suite 203

Austin TX 78746

United States of America

+1 (512) 988-2454

EMAIL

info [at] camin.com

follow

LinkedIn

Cambridge Innovation Consulting is an ISO certified organisation with 27001:2013 (# 317252019) and 9001:2015 (# 317242019) certifications.

COPYRIGHT 2019 - Cambridge Innovation Consulting